About RosamondRosamond advises clients on equity capital markets and both public and private mergers and acquisitions. She has recently advised on a number of major IPOs in the Australian market. Rosamond also has extensive experience advising both Australian and foreign clients listed on ASX and other foreign securities exchanges on their capital raising, Listing Rules and Australian securities law matters.
Advising Atomos on its pre-IPO round and subsequent IPO and listing on the ASX and subsequent sale facility of $27 million worth of shares released from escrow and further capital raisings.
Advising Revasum Inc (US company incorporated in Delaware) on its pre-IPO round and subsequent IPO and ASX listing on the ASX.
Pivotal Systems Corporation
Advising Pivotal (US company incorporated in Delaware) on its pre-IPO round and subsequent IPO and ASX listing. Also advised on its recent funding of US$13 million by way of revenue based preferred stock.
Moelis Australia, Shaw and Partners and Morgans
Acted for Moelis Australia, Shaw and Partners and Morgans as joint lead managers on the IPO and ASX listing of the 360 Capital Digital Infrastructure Fund.
Acted for Moelis Australia in the IPO and ASX listing of Imricor Medical Systems, Inc (a US medical devices company).
Advising on tech company IPOs
Maddocks has advised US-based tech company Pivotal Systems on their successful IPO and listing on the ASX
Maddocks advises Revasum on latest capital raising
Maddocks has assisted US-based tech company Revasum on its A$7.9 million capital raising.
Maddocks advises on eCommerce IPO
We have advised Australian eCommerce company MyDeal.com.au Limited on its $40 million IPO and listing on the ASX
Year-end earnings surprises and continuous disclosure: COVID-19 impact
With the financial year end (or half year) looming for many companies and the impact of COVID-19 over the last few...
Are you up to date? 30 June deadline for corporate governance policies is looming
ASX listed companies with a 30 June balance date need to update their corporate governance policies by 30 June 2020